ScoreComparison
Why is ADMA Biologics, Inc. ?
1
The company is Net-Debt Free
2
Healthy long term growth as Net Sales has grown by an annual rate of 64.60%
3
Flat results in Mar 26
- NET PROFIT(HY) At USD 94.71 MM has Grown at -32.37%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.33 times
4
With ROE of 31.34%, it has a expensive valuation with a 4.62 Price to Book Value
- Over the past year, while the stock has generated a return of -51.69%, its profits have fallen by -24.8%
5
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 25.22% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -51.69% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to ADMA Biologics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is ADMA Biologics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
ADMA Biologics, Inc.
-51.69%
-0.33
54.72%
S&P 500
25.22%
1.91
13.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
64.60%
EBIT Growth (5y)
37.69%
EBIT to Interest (avg)
0.77
Debt to EBITDA (avg)
0.83
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.99
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.78%
ROE (avg)
14.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.62
EV to EBIT
11.43
EV to EBITDA
10.97
EV to Capital Employed
4.73
EV to Sales
4.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
41.35%
ROE (Latest)
31.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 128.32 MM
RAW MATERIAL COST(Y)
Fallen by -33.1% (YoY
CASH AND EQV(HY)
Highest at USD 225.78 MM
PRE-TAX PROFIT(Q)
At USD 57.13 MM has Grown at 70.78%
NET PROFIT(Q)
At USD 45.33 MM has Grown at 68.48%
-10What is not working for the Company
NET PROFIT(HY)
At USD 94.71 MM has Grown at -32.37%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.33 times
NET SALES(Q)
Lowest at USD 114.49 MM
INTEREST(Q)
Highest at USD 2.1 MM
Here's what is working for ADMA Biologics, Inc.
Operating Cash Flow
Highest at USD 128.32 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD 57.13 MM has Grown at 70.78%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 45.33 MM has Grown at 68.48%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Cash and Eqv
Highest at USD 225.78 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -33.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ADMA Biologics, Inc.
Interest
At USD 2.1 MM has Grown at 29.15%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Sales
Lowest at USD 114.49 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Interest
Highest at USD 2.1 MM
in the last five periods and Increased by 29.15% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 1 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 4.33 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
